On Tuesday, M3 USA’s MDLinx, a pharma advertising supported informational website for physicians, launched a new quiz – The SmartestDoc – for internal medicine and family physicians. In collaboration with MDLinx, the Cleveland Clinic is providing educational materials from its Center for Continuing Education to be used in the quiz,
By challenging physicians to be The SmartestDoc, MDLinx and the Cleveland Clinic are using competition to promote education.
Stephen Smith
On Tuesday, M3 USA’s MDLinx, a pharma advertising supported informational website for physicians, launched a new quiz – The SmartestDoc – for internal medicine and family physicians. In collaboration with MDLinx, the Cleveland Clinic is providing educational materials from its Center for Continuing Education to be used in the quiz, which tests a physician’s knowledge of recent medical literature, practice-related issues, and other med ed topics. While the quiz itself isn’t new, the Cleveland Clinic’s participation and provision of materials will bring new physicians into the competition.
The five-question quiz, which hopes to reach roughly 200,000 US docs in the first 90 days, allows registered physicians to quiz themselves once a day, and then see how their scores shape up against other physicians regionally and nationally. Anyone can take the daily quiz, and revisit past quizzes for review, but only verified physicians are included in the leaderboard. Each month, the doc with the most points will receive a certificate deeming him or her the “Smartest Family Physician.” Physicians can also form teams of five and compete against other teams. Quizzes are ranked by difficulty, and physicians can evaluate their strengths according to different practice areas. “There are performance pages – private to the physician – that measure expertise levels, and how they stack up against the community,” says Stephen Smith, chief marketing officer at M3, owner of MDLinx.
Smith says that content contributions from the Cleveland Clinic augment the quiz by giving it “a better blend…in addition to the new medical literature, there’s now enduring educational materials. It’s the mix of material that provides a robust learning environment.” Staff editors at MDLinx convert the materials received from the Cleveland Clinic into quiz questions.
As of now, the quizzes don’t offer CME credits, but Smith says he hopes to add this capability in the future. MDLinx has had preliminary discussions about integrating the quiz into live meetings as well as a certification review course, according to Smith.
Sanofi Bolsters Immunology Pipeline with Acquisition of Dren Bio’s DR-0201 for Up to $1.9 Billion
March 20th 2025DR-0201, a CD20-directed bispecific antibody, has demonstrated robust B-cell depletion in early clinical studies, showing promise in treating refractory B-cell-mediated autoimmune diseases.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
March 19th 2025In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a ≥50% reduction in the total abscess and inflammatory nodule count.